Stay updated on TransCon IL-2 β/γ Clinical Trial
Sign up to get notified when there's something new on the TransCon IL-2 β/γ Clinical Trial page.

Latest updates to the TransCon IL-2 β/γ Clinical Trial page
- Check3 days agoChange DetectedRecruitment status updated to indicate enrollment has ended. The history adds Revision: v3.6.0 and removes Revision: v3.5.5.SummaryDifference0.3%

- Check10 days agoChange DetectedThe Record History now shows a new Revision: v3.5.5 entry, indicating a newer update to the record's metadata and replacing the previous v3.5.4 marker.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedA new revision entry, v3.5.4, was added to the record history and the previous revision, v3.5.3, was removed.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page’s revision/version label has been updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check61 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the history.SummaryDifference0.1%

- Check89 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 in the page history.SummaryDifference0.1%

Stay in the know with updates to TransCon IL-2 β/γ Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TransCon IL-2 β/γ Clinical Trial page.